Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Sindern

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Journal of Neuroimmunology|December 10, 1998
Immunomodulatory effects of interferon-beta-1b in vivo: induction of the expression of transforming growth factor-beta1 and its receptor type IIL M Ossege, E Sindern, T Patzold, et al.
Acta Neurologica Scandinavica|August 1, 1997
Biologically active TGF-beta 1 is increased in cerebrospinal fluid while it is reduced in serum in multiple sclerosis patientsJ D Rollnik, E Sindern, C Schweppe, et al.
Journal of Neuroimmunology|May 26, 1998
Corticosteroids induce expression of transforming-growth-factor-beta1 mRNA in peripheral blood mononuclear cells of patients with multiple sclerosisL M Ossege, E Sindern, B Voss, et al.
Immunopharmacology|August 7, 1999
Immunomodulatory effects of IFNbeta-1b on the mRNA-expression of TGFbeta-1 and TNFalpha in vitroL M Ossege, E Sindern, B Voss, et al.
International Immunopharmacology|June 16, 2001
Immunomodulatory effects of interferon-beta-1b in patients with multiple sclerosisL M Ossege, E Sindern, T Patzold, et al.
Journal of Neurology|December 5, 1998
The soluble 60-kDa tumour necrosis factor receptor: no difference found between patients with relapsing-remitting multiple sclerosis and controls: increasing levels are associated with the recovery from Guillain-Barré syndromeT Patzold, E Sindern, L Ossege-Pohle, et al.
Journal of Neurology|March 1, 1996
Potential role of transforming growth factor-beta 1 in terminating the immune response in patients with Guillain-Barré syndromeE Sindern, K Schweppe, L M Ossege, et al.
Journal of Neuroimmunology|November 7, 2006
Increase of CD8+ T-effector memory cells in peripheral blood of patients with relapsing-remitting multiple sclerosis compared to healthy controlsK F Haegele, C A Stueckle, J-P Malin, et al.
Acta Neuropathologica|September 29, 1999
Polyneuropathy with osmiophilic membrane-bound, cytoplasmic inclusions in Schwann cells (POMCIS)J M Schröder, J F Wang, E Sindern, et al.
Acta Neurologica Scandinavica|December 19, 1998
Analysis of lymphocyte subpopulations in cerebrospinal fluid and peripheral blood in patients with multiple sclerosis and inflammatory diseases of the nervous systemC Oreja-Guevara, E Sindern, M Raulf-Heimsoth, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Journal of Neuroimmunology|December 10, 1998
Immunomodulatory effects of interferon-beta-1b in vivo: induction of the expression of transforming growth factor-beta1 and its receptor type IIL M Ossege, E Sindern, T Patzold, et al.
Acta Neurologica Scandinavica|August 1, 1997
Biologically active TGF-beta 1 is increased in cerebrospinal fluid while it is reduced in serum in multiple sclerosis patientsJ D Rollnik, E Sindern, C Schweppe, et al.
Journal of Neuroimmunology|May 26, 1998
Corticosteroids induce expression of transforming-growth-factor-beta1 mRNA in peripheral blood mononuclear cells of patients with multiple sclerosisL M Ossege, E Sindern, B Voss, et al.
Immunopharmacology|August 7, 1999
Immunomodulatory effects of IFNbeta-1b on the mRNA-expression of TGFbeta-1 and TNFalpha in vitroL M Ossege, E Sindern, B Voss, et al.
International Immunopharmacology|June 16, 2001
Immunomodulatory effects of interferon-beta-1b in patients with multiple sclerosisL M Ossege, E Sindern, T Patzold, et al.
Journal of Neurology|December 5, 1998
The soluble 60-kDa tumour necrosis factor receptor: no difference found between patients with relapsing-remitting multiple sclerosis and controls: increasing levels are associated with the recovery from Guillain-Barré syndromeT Patzold, E Sindern, L Ossege-Pohle, et al.
Journal of Neurology|March 1, 1996
Potential role of transforming growth factor-beta 1 in terminating the immune response in patients with Guillain-Barré syndromeE Sindern, K Schweppe, L M Ossege, et al.
Journal of Neuroimmunology|November 7, 2006
Increase of CD8+ T-effector memory cells in peripheral blood of patients with relapsing-remitting multiple sclerosis compared to healthy controlsK F Haegele, C A Stueckle, J-P Malin, et al.
Acta Neuropathologica|September 29, 1999
Polyneuropathy with osmiophilic membrane-bound, cytoplasmic inclusions in Schwann cells (POMCIS)J M Schröder, J F Wang, E Sindern, et al.
Acta Neurologica Scandinavica|December 19, 1998
Analysis of lymphocyte subpopulations in cerebrospinal fluid and peripheral blood in patients with multiple sclerosis and inflammatory diseases of the nervous systemC Oreja-Guevara, E Sindern, M Raulf-Heimsoth, et al.
Pageof 4